Literature DB >> 12039958

Constitutive JNK activation in NIH 3T3 fibroblasts induces a partially transformed phenotype.

Ulrike E E Rennefahrt1, Bertram Illert, Eugen Kerkhoff, Jakob Troppmair, Ulf R Rapp.   

Abstract

The c-Jun N-terminal kinases (JNKs) (also known as stress-activated protein kinases or SAPKs), members of the mitogen-activated protein kinase (MAPK) family, regulate gene expression in response to a variety of physiological and unphysiological stimuli. Gene knockout experiments and the use of dominant interfering mutants have pointed to a role for JNKs in the processes of cell differentiation and survival as well as oncogenic transformation. Direct analysis of the transforming potential of JNKs has been hampered so far by the lack of constitutively active forms of these kinases. Recently, such mutants have become available by fusion of the MAPK with its direct upstream activator kinase. We have generated a constitutively active SAPK beta-MKK7 hybrid protein and, using this constitutively active kinase, we are able to demonstrate the transforming potential of activated JNK, which is weaker than that of classical oncogenes such as Ras or Raf. The inducible expression of SAPK beta-MKK7 caused morphological transformation of NIH 3T3 fibroblasts. Additionally, these cells formed small foci of transformed cells and grew anchorage-independent in soft agar. Furthermore, similar to oncogenic Ras and Raf, the expression of activated SAPK beta resulted in the disassembly of F-actin stress fibers. Our data suggest that constitutive JNK activation elicits major aspects of cellular transformation but is unable to induce the complete set of changes which are required to establish the fully transformed phenotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039958     DOI: 10.1074/jbc.M203010200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Differential gene expression in stromal cells of human giant cell tumor of bone.

Authors:  M Wuelling; G Delling; E Kaiser
Journal:  Virchows Arch       Date:  2004-09-23       Impact factor: 4.064

2.  Measuring the constitutive activation of c-Jun N-terminal kinase isoforms.

Authors:  Ryan T Nitta; Shawn S Badal; Albert J Wong
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

3.  Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes.

Authors:  Hideya Mizuno; Yong-Yeon Cho; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Mol Carcinog       Date:  2006-01       Impact factor: 4.784

4.  Involvement of stress kinase mitogen-activated protein kinase kinase 7 in regulation of mammalian circadian clock.

Authors:  Yoshimi Uchida; Tomomi Osaki; Tokiwa Yamasaki; Tadanori Shimomura; Shoji Hata; Kazumasa Horikawa; Shigenobu Shibata; Takeshi Todo; Jun Hirayama; Hiroshi Nishina
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

5.  Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation.

Authors:  Jinhua Wang; Isere Kuiatse; Adrian V Lee; Jingxuan Pan; Armando Giuliano; Xiaojiang Cui
Journal:  Mol Cancer Res       Date:  2010-02-09       Impact factor: 5.852

6.  Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model.

Authors:  Heather S Floyd; Charles L Farnsworth; Nancy D Kock; Melissa C Mizesko; Joy L Little; Stephanie T Dance; Jeff Everitt; Jay Tichelaar; Jeffrey A Whitsett; Mark Steven Miller
Journal:  Carcinogenesis       Date:  2005-07-28       Impact factor: 4.944

7.  Mixed lineage kinase 3 is required for matrix metalloproteinase expression and invasion in ovarian cancer cells.

Authors:  Yu Zhan; Widian F Abi Saab; Nidhi Modi; Amanda M Stewart; Jinsong Liu; Deborah N Chadee
Journal:  Exp Cell Res       Date:  2012-05-28       Impact factor: 3.905

8.  Rac1 signaling modulates BCL-6-mediated repression of gene transcription.

Authors:  Patrícia Barros; Peter Jordan; Paulo Matos
Journal:  Mol Cell Biol       Date:  2009-06-01       Impact factor: 4.272

9.  Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer.

Authors:  Y Zhan; N Modi; A M Stewart; R I Hieronimus; J Liu; D H Gutmann; D N Chadee
Journal:  Oncogene       Date:  2010-10-04       Impact factor: 9.867

10.  Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription.

Authors:  Zahid Nawaz; Vikas Patil; Anjali Arora; Alangar S Hegde; Arimappamagan Arivazhagan; Vani Santosh; Kumaravel Somasundaram
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.